Calcium plus vitamin D supplementation during pregnancy reduces postpartum fat mass in adolescents: A randomized trial
- PMID: 37166151
- DOI: 10.1002/ajhb.23911
Calcium plus vitamin D supplementation during pregnancy reduces postpartum fat mass in adolescents: A randomized trial
Abstract
Background: Pregnancy during adolescence may increase the risk of overweight/obesity. There is evidence that increasing calcium intake, alone or vitamin D-combined, may favor loss of weight and/or fat mass.
Objectives: We hypothesized that calcium supplementation during pregnancy reduces excessive fat accumulation during postpartum period. We aimed to investigate the effect of calcium plus vitamin D supplementation during pregnancy on body composition measurements throughout 1 year postpartum in Brazilian adolescents with habitually low calcium intake (~600 mg/day).
Methods: Adolescents (14-19 years) were randomly assigned to receive a daily supplement (600 mg of calcium plus 200 UI of cholecalciferol, n = 30) or a placebo (n = 26) from 26 weeks of gestation until parturition. Body composition was determined at 5, 20, and 56 weeks postpartum by dual-energy x-ray absorptiometry. The effects of intervention group, time point, as well as their interaction were assessed using repeated measures mixed-effects models.
Results: In the adjusted analysis, those supplemented showed lower total body mass [mean difference = -3.32 kg; confidence interval (CI) 95% -6.12 to -0.52 kg], trunk (-1.25 kg; CI 95% -2.34 to -0.15 kg), android (-0.29 kg; CI 95% -0.53 to -0.04 kg) and subcutaneous (-0.23 kg; CI 95% -0.43 to -0.03 kg) fat masses. In the supplemented group, BMI and postpartum weight retention significantly decreased from 5 to 20 weeks (-0.90 kg/m2 and -1.76 kg, respectively; p < .05). At 56 weeks, BMI was still lower (-1.22 kg/m2 ; p < .05) than 5 weeks.
Conclusions: Our findings suggest that increasing calcium intake through supplementation in combination with vitamin D contributes to a more pronounced reduction in total body mass overtime, mostly as a consequence of fat mass reductions in central body regions. This trial was registered at clinicaltrials.gov as NCT01732328.
© 2023 Wiley Periodicals LLC.
References
REFERENCES
-
- Achari, A., & Jain, S. (2017). Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction. International Journal of Molecular Sciences, 18, 1321-1337. https://doi.org/10.3390/ijms18061321
-
- Arendas, K., Qiu, Q., & Gruslin, A. (2008). Obesity in pregnancy: Pre-conceptional to postpartum consequences. Journal of Obstetrics and Gynaecology Canada, 30, 477-488. https://doi.org/10.1016/S1701-2163(16)32863-8
-
- Bezerra, F. F., Cabello, G. M., Mendonça, L. M., & Donangelo, C. M. (2008). Bone mass and breast milk calcium concentration are associated with vitamin D receptor gene polymorphisms in adolescent mothers. Journal of Nutrition, 138, 277-281. https://doi.org/10.1093/jn/138.2.277
-
- Bezerra, F. F., Laboissière, F. P., King, J. C., & Donangelo, C. M. (2002). Pregnancy and lactation affect markers of calcium and bone metabolism differently in adolescent and adult women with low calcium intakes. Journal of Nutrition, 132, 2183-2187. https://doi.org/10.1093/jn/132.8.2183
-
- Bezerra, F. F., Normando, P., Fonseca, A. C. P., Zembrzuski, V., Campos-Junior, M., Cabello-Acero, P. H., & Faerstein, E. (2022). Genetic, sociodemographic and lifestyle factors associated with serum 25-hydroxyvitamin D concentrations in Brazilian adults: The Pró-Saúde study. Cadernos de Saúde Pública, 38, e00287820. https://doi.org/10.1590/0102-311X00287820
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources